This inclusivity reflects our commitment to holistic care
Providing increasing doses of LT4 therapy The optimal treatment for hypothyroidism remains a subject of debate, with the etiology and severity of hypothyroidism and the amount of residual functional thyroid tissue affecting the LT4 dosage (23, 24) Moreover, in light of the complexities surrounding thyroid hormone homeostasis, a one-size-fits-all approach to TSH targets may be inappropriate, particularly given the interindividual variability in TSH set-points and peripheral hormone metabolism (8, 23, 25)
The synthetic peptide is a chain of 15 amino acids
BPC-157: the gastric-derived pentadecapeptide BPC-157 (Body Protection Compound-157) is a stable synthetic pentadecapeptide of 15 amino acids, originally isolated from a larger protective protein found in gastric juice
Semaglutide, approved for type 2 diabetes in 2017 and for obesity in 2021, is a fully human GLP-1 receptor agonist
Very little metabolic effect
